课题基金 / 基金详情

项目摘要

项目成果

ROY E WEISS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application is for a Midcareer Investigator Award in Patient-Oriented research (K24). It is intended to provide support for Roy Weiss as a clinical investigator to devote focused time for patient orientated research and to act as a mentor for beginning clinical investigators. Dr. Weiss' accomplishments as a clinical investigator and mentor for medical students, residents and fellows make this goal realistic. The research plan is to investigate the role of nuclear cofactors regulating thyroid physiology and disease in man. Thyroid hormone (TH) is essential for normal growth and development as well as maintenance of metabolic activity in the adult. TH action is mediated by intranuclear thyroid hormone receptors (TRs) which regulate the transcription of hormone responsive genes. Coregulators are nuclear proteins which interact with liganded or unliganded nuclear receptors to further modulate the transcription of TR targeted genes. The coregulators may either be corepressors, which inhibit transcription in the absence of TH, or coactivators which stimulate transcriptional activation of the liganded TR. The hypothesis guiding the proposed studies is that defects in cofactors or TRs involved in the mediation of TH action are responsible for the manifestation of diseases of thyroid hormone responsiveness, namely, resistance to TH (RTH) and hypersensitivity to TH. It is proposed to: (1) search in vivo for subtle resistance to glucocorticoids and sex hormones in patients with RTH with and without TR mutations. Identification of such defects will help define the in vivo function of specific cofactors in man. (2) Determine if variability in the phenotype of RTH is due to differences in cofactors that modulate TH action. (3) Determine the cause for hypersensitivity to TH. This will allow clinicians to better identify factors influencing thyroid function.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.
吡格列酮对库欣病促肾上腺皮质激素和皮质醇分泌的影响。
DOI: 10.1210/jc.2004-1746
发表时间: 2005
期刊: The Journal of clinical endocrinology and metabolism.
影响因子: --
作者: [Suri,Daesman, Weiss,RoyE]
通讯作者: Weiss,RoyE
Tissue responses to thyroid hormone in a kindred with resistance to thyroid hormone harboring a commonly occurring mutation in the thyroid hormone receptor beta gene (P453T).
甲状腺激素抗性家族中甲状腺激素的组织反应,其中甲状腺激素受体β基因(P453T)经常发生突变。
DOI: 10.1016/j.lab.2005.04.005
发表时间: 2005
期刊: The Journal of laboratory and clinical medicine.
影响因子: --
作者: [Wu,SharonY, Sadow,PeterM, Refetoff,Samuel, Weiss,RoyE]
通讯作者: Weiss,RoyE
Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouse.
阿黑皮质素原缺乏小鼠的下丘脑-垂体-甲状腺轴异常。
DOI: 10.1016/j.regpep.2004.06.012
发表时间: 2004
期刊: Regulatory peptides.
影响因子: --
作者: [Martin,NiamhM, Small,CarolineJ, Sajedi,Arshia, Liao,XiaoH, Weiss,RoyE, Gardiner,JamesV, Ghatei,MohammadA, Bloom,StephenR]
通讯作者: Bloom,StephenR
A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.
一种新型甲状腺激素受体β突变,无法与患者体内的核受体辅阻遏物结合,是导致垂体对甲状腺激素产生严重抵抗的明显原因。
DOI: 10.1210/jc.2005-2428
发表时间: 2006
期刊: The Journal of clinical endocrinology and metabolism.
影响因子: --
作者: [Wu,SharonY, Cohen,RonaldN, Simsek,Enver, Senses,DursunA, Yar,NeseE, Grasberger,Helmut, Noel,Janet, Refetoff,Samuel, Weiss,RoyE]
通讯作者: Weiss,RoyE
6
    RESISTANCE TO THYROID HORMONE
    • 批准号:
      7604743
    • 项目类别:
    • 资助金额:
      $1.35万
    • 财政年份:
      2007
    • 负责人:
      ROY E WEISS
    • 依托单位:
    STUDIES OF CUSHING'S DISEASE
    • 批准号:
      7604780
    • 项目类别:
    • 资助金额:
      $1.07万
    • 财政年份:
      2007
    • 负责人:
      ROY E WEISS
    • 依托单位:
    250 MICROGRAM ACTH STIMULATION TEST IN PREGNANCY
    • 批准号:
      7378634
    • 项目类别:
    • 资助金额:
      $1.26万
    • 财政年份:
      2006
    • 负责人:
      ROY E WEISS
    • 依托单位:
    THE ROLE OF CORTISOL IN GESTATIONAL DIABETES MELLITUS
    • 批准号:
      7378636
    • 项目类别:
    • 资助金额:
      $0.63万
    • 财政年份:
      2006
    • 负责人:
      ROY E WEISS
    • 依托单位:
    国内基金
    海外基金
    Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data